Your browser doesn't support javascript.
loading
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
Hicks, Karen A; Mahaffey, Kenneth W; Mehran, Roxana; Nissen, Steven E; Wiviott, Stephen D; Dunn, Billy; Solomon, Scott D; Marler, John R; Teerlink, John R; Farb, Andrew; Morrow, David A; Targum, Shari L; Sila, Cathy A; Thanh Hai, Mary T; Jaff, Michael R; Joffe, Hylton V; Cutlip, Donald E; Desai, Akshay S; Lewis, Eldrin F; Gibson, C Michael; Landray, Martin J; Lincoff, A Michael; White, Christopher J; Brooks, Steven S; Rosenfield, Kenneth; Domanski, Michael J; Lansky, Alexandra J; McMurray, John J V; Tcheng, James E; Steinhubl, Steven R; Burton, Paul; Mauri, Laura; O'Connor, Christopher M; Pfeffer, Marc A; Hung, H M James; Stockbridge, Norman L; Chaitman, Bernard R; Temple, Robert J.
Afiliación
  • Hicks KA; Division of Cardiovascular and Renal Products, Office of Drug Evaluation I, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), Silver Spring, Maryland. Electronic address: karen.hicks@fda.hhs.gov.
  • Mahaffey KW; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Mehran R; Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Nissen SE; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
  • Wiviott SD; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Dunn B; Division of Neurology Products, Office of Drug Evaluation I, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), Silver Spring, Maryland.
  • Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Marler JR; Division of Neurology Products, Office of Drug Evaluation I, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), Silver Spring, Maryland.
  • Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, California.
  • Farb A; Division of Cardiovascular Devices, Center for Devices and Radiological Health (CDRH), United States Food and Drug Administration (FDA), Silver Spring, Maryland.
  • Morrow DA; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Targum SL; Division of Cardiovascular and Renal Products, Office of Drug Evaluation I, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), Silver Spring, Maryland.
  • Sila CA; Neurological Institute, University Hospitals-Cleveland Medical Center, Cleveland, Ohio.
  • Thanh Hai MT; Office of Drug Evaluation II, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), Silver Spring, Maryland.
  • Jaff MR; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Joffe HV; Division of Bone, Reproductive and Urologic Products, Office of Drug Evaluation III, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), Silver Spring, Maryland.
  • Cutlip DE; Cardiology Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Lewis EF; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Gibson CM; Cardiovascular Division, Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Landray MJ; Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), University of Oxford, Oxford, United Kingdom.
  • Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
  • White CJ; Department of Cardiology, Ochsner Clinical School, New Orleans, Louisiana.
  • Brooks SS; Brooks Medtech, LLC, Reisterstown, Maryland.
  • Rosenfield K; Vascular Medicine and Intervention, Corrigan Minehan Heart Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Domanski MJ; Peter Munk Cardiac Centre, University Health Network/Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Lansky AJ; Department of Internal Medicine, Section of Cardiology, Yale School of Medicine, New Haven, Connecticut.
  • McMurray JJV; Institute of Cardiovascular & Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland.
  • Tcheng JE; Division of Cardiovascular Medicine, Duke University Medical Center, Durham, North Carolina.
  • Steinhubl SR; Division of Digital Medicine, Scripps Translational Science Institute, La Jolla, California.
  • Burton P; Cardiovascular and Metabolism Medical Affairs, Janssen Pharmaceuticals Inc., Titusville, New Jersey.
  • Mauri L; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • O'Connor CM; Division of Cardiology, Inova Heart & Vascular Institute, Falls Church, Virginia.
  • Pfeffer MA; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.
  • Hung HMJ; Division of Biometrics I, Office of Biostatistics, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), Silver Spring, Maryland.
  • Stockbridge NL; Division of Cardiovascular and Renal Products, Office of Drug Evaluation I, Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), Silver Spring, Maryland.
  • Chaitman BR; Center for Comprehensive Cardiovascular Care, St. Louis University School of Medicine, St. Louis, Missouri.
  • Temple RJ; Center for Drug Evaluation and Research (CDER), United States Food and Drug Administration (FDA), Silver Spring, Maryland.
J Am Coll Cardiol ; 71(9): 1021-1034, 2018 03 06.
Article en En | MEDLINE | ID: mdl-29495982
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Ensayos Clínicos como Asunto / Accidente Cerebrovascular / Determinación de Punto Final Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Coll Cardiol Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Ensayos Clínicos como Asunto / Accidente Cerebrovascular / Determinación de Punto Final Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Am Coll Cardiol Año: 2018 Tipo del documento: Article